- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
PAGE \* MERGEFORMAT 9
Agents how to avoid the ‘wedding dress’ nightmare?
March 27, 2003, Nanjing Simcere Pharmaceutical Group, 8-year-old’s birthday the day before, Nanjing ‘Yangzi Evening News’ published a ‘crisis-peers’ in frontreport, the title at first glance looks very happy proportionality, it is 8 years Simcere Pharmaceutical highly unusual course of development of a true portrayal.
Simcere are doing marketing, started out as a dealer, the precursor has its own interests and ideas, many of them contrary to the interests of those with the factory. The task is how to coordinate the manufacturers and distributors to contain the power of the factory to a favorable direction, so, again doped Yushuiguanxi scenes battle of wits among the stories. At this point, harbinger, general manager Ren Jinsheng exposed face of a traumatic left by the vicissitudes of life.
〖 General Distribution ‘eternal pain’〗
Simcere Pharmaceutical, this year started with a single trade enterprises in China’s pharmaceutical industry there are two no-one can go beyond the glory: China’s first choice for general distribution, general agent marketing model, rather than generic drugs business of pharmaceutical wholesale business enterprise; also is the first choice for the national industrial enterprises of the total pharmaceutical distribution partners, commercial enterprises. There is no doubt herald understanding the relationship between the firms can be described as penetrating.
Between the distributors and manufacturers in the end what should be the kind of relationship? In most cases, market development, training stage, the majority of dealers and manufacturers can fight side by side, because the two sides who can not who is also missing is a common interest so that we can work together, when the vendors is ‘Yushuiguanji’. However, in the eyes of some manufacturers, large distributors will eventually be a springboard. As a result, agent system are common to a breathtaking sum of
您可能关注的文档
- After the medical reform agency business transformation needed a reserve price-.doc
- After the monopoly era C2C Jane Long chess game.doc
- After the oral compound abortion clinical study of short-acting contraceptive_0.doc
- After the oral compound abortion clinical study of short-acting contraceptive.doc
- After the PPG era Vancl how to carry the banner of apparel B2C-.doc
- After the rapid expansion of sales force Thoughts and Suggestions.doc
- After the right wall of lower uterine segment on a large hematoma caused by obstruction of the soft birth dystocia in 1 case.doc
- After the removal of the side of testicular torsion in rats on the other side of the protective effect of testicular tissue.doc
- After the rise of consumer awareness ... ....doc
- After the rum then marketing.doc
- Agents How to choose a new project-.doc
- Agents how to live better-.doc
- Agents How to choose the new product.doc
- Agents have to do make-up brand of choice.doc
- Agents how to make cosmetics store.doc
- Agents also brand.doc
- Agents how to plan their own development.doc
- Agents Beware of 'margin' Trap.doc
- Agents How to self-enhancement-.doc
- Agents 'individual heroism'.doc
最近下载
- 博士Panaray 402 II 扬声器说明书.pdf
- DD 2022-1.3 岩心数字化技术规程 第3部分:光谱扫描.pdf VIP
- 最新一级建造师继续教育论文(可编辑).doc VIP
- 干部监督流程图.xls VIP
- 二手机器设备买卖协议书4篇.docx
- 实验室准入教育答案(通识A课程).docx VIP
- 家用升降梯设计-小型剪叉式液压升降机.doc VIP
- 《时间序列分析——基于Python》 课件全套 王燕 第1--7章 时间序列分析方法发展概述---多元时间序列分析.pptx VIP
- 2024年10月19日湖北省联考遴选笔试真题及答案解析(市级卷).doc VIP
- 中国视网膜静脉阻塞临床诊疗路径专家共识.pdf VIP
文档评论(0)